Safety

Melanotan II

Adverse-event report summary for Melanotan II, drawn from the FDA Adverse Event Reporting System (FAERS).

Total reports
9
Reports flagged serious
8

“Serious” is FAERS’s own report-level flag (e.g. death, hospitalization, or another outcome the reporter marked as serious) and does not indicate a verified or compound-caused outcome.

Most frequently reported reactions

  1. Renal Artery Thrombosis5 reports
  2. Renal Infarct3 reports
  3. Melanocytic Naevus1 reports
  4. Product Advertising Issue1 reports
  5. Product Use Issue1 reports
  6. Skin Texture Abnormal1 reports

Counts reflect the most-reported reaction terms (MedDRA preferred terms) associated with reports naming this compound. A single report can list multiple reactions, so reaction counts need not sum to the total number of reports.